A new study investigates the ‘obesity paradox,’ which refers to the fact that excess body fat may be a cancer risk, but could also improve a patient’s response to cancer treatment in certain cases. The new research comes out of Flinders University, where scientists looked into clinical trials involving an immunotherapy treatment used for non-small-cell lung cancer called atezolizumab. Patients …